New pump could make dialysis access easier for kidney patients

NCT ID NCT07211035

Recruiting now Disease control Sponsor: Amplifi Vascular, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a device called the Amplifi Vein Dilation System, which is a temporary blood pump used before creating a dialysis access point (fistula) in the arm. The goal is to see if it helps widen small veins so the fistula works better for dialysis. About 160 adults with end-stage kidney disease who need dialysis will take part. Some will get the device plus standard fistula surgery, while others will have surgery alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Amplifi Vein Dilation System (a temporary blood pump device)
What this could lead to: If it works, this device could help more kidney patients get working dialysis access without needing extra surgeries or catheters.
What could go wrong: This is an early-stage device trial with 160 participants, so results may not apply to everyone. There are risks from the pump and vein procedure, including injury or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE KIDNEY DISEASE (ESRD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

END STAGE KIDNEY DISEASE (ESRD)

Contacts and locations

Locations

Brigham Women's Hospital
RECRUITING

Boston, Massachusetts, 02115, United States
Flow Vascular
RECRUITING

Houston, Texas, 77091, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.